Search Results (7,180)

Simultaneous monitoring of antimicrobial responses to bacterial metabolic activity and biofilm formation is critical for efficient screening of new anti-biofilm drugs. A microbial fuel cell-based biosensor using Pseudomonas aeruginosa as an electricigen was constructed. The effects of silver nanoparticles (AgNPs) on the cellular metabolic activity and biofilm formation of P. aeruginosa in the biosensors were investigated and compared with the traditional biofilm detection method. The crystal violet staining results showed that the concentration of AgNPs being increased to 20 and 40 μg/mL had a slight and obvious inhibitory effect on biofilm formation, respectively. In comparison, the detection sensitivity of the biosensor was much higher. When the concentration of AgNPs was 5 μg/mL, the output voltage of the biosensor was suppressed, and the inhibition gradually increased with the AgNPs dose. AgNPs inhibited the activity of planktonic cells in the anolyte and the formation of biofilm on the anode surface, and it had a dose-dependent effect on the secretion of phenazine in the anolyte. The biosensor could monitor the impacts of AgNPs not only on biofilm formation but also on cell activity and metabolic activity. It provides a new and sensitive method for the screening of anti-biofilm drugs. Full article

Liquid biopsy is an efficient diagnostic/prognostic tool for tumor-derived component detection in peripheral circulation and other body fluids. The rapid assessment of liquid biopsy techniques facilitates early cancer diagnosis and prognosis. Early and precise detection of tumor biomarkers provides crucial information about the tumor that guides clinicians towards effective personalized medicine. Point-of-care-testing remains still a great challenge in cancer diagnostics. Liquid biopsy is a promising alternative to tissue biopsy with the great advantages of less invasion and real-time monitoring of the disease, also providing information about tumor heterogeneity. The field is continuously and rapidly expanding. Numerous sophisticated biosensors have been developed targeting several biomarkers to achieve low detection limits, increased specificity and robustness. Current biosensors include mainly optical sensors, such as colorimetric, fluorescent, SPR, SERS and lateral flow assays. Electrochemical sensors have also been developed, providing very low detection limits. Colorimetric sensors exhibited simplicity in signal interpretation, while fluorescent sensors contributed to low analysis times, and SPR/SERS enabled label-free and rapid analysis. Novel target amplification and signal enhancement techniques have been exploited to increase the detectability of the sensors. In this context, this review is focused on the recent advances in biosensing technology for cutting-edge liquid biopsy applications towards point-of-care testing. Full article

Non-small cell lung cancer (NSCLC) is the predominant form of lung cancer and poses a significant public health challenge. Early detection is crucial for improving patient outcomes, with serum biomarkers such as carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCAg), and cytokeratin fragment 19 (CYFRA 21-1) playing a critical role in early screening and pathological classification of NSCLC. However, due to being mainly based on corresponding antibody binding reactions, existing detection technologies for these serum biomarkers have shortcomings such as complex operations, high false positive rates, and high costs. This study aimed to develop new methods for detecting CEA, SCCAg, and CYFRA 21-1 to assist in the diagnosis of NSCLC. Affinity peptides of CEA, SCCAg, and CYFRA 21-1, respectively, were screened by phage display technology, and the peptides’ binding affinities were determined by enzyme-linked immunosorbent assay and biolayer interferometry. Peptides with high affinity were then integrated as binding domains into biosensors by fusing them with circularly permuted fluorescent proteins (cpFPs) through genetic coding. The resulting biosensors, C4 biosensor for CEA, S1 biosensor for SCCAg, and Y3 biosensor for CYFRA 21-1, demonstrated robust sensitivity and specificity even at concentrations as low as 1 ng/mL for their respective tumor markers. When applied to clinical samples and recalibrated for the upper limit of normal concentrations, the biosensors exhibited enhanced sensitivity and specificity for NSCLC diagnosis. This study introduced innovative biosensors for the detection of CEA, SCCAg, and CYFRA 21-1, providing a highly sensitive, specific, rapid, and cost-effective diagnostic alternative that could significantly improve NSCLC screening rates. Full article

A battery-operated biomedical wearable device gradually assists in clinical tasks to monitor patients’ health states regarding early diagnosis and detection. This paper presents the development of a self-powered portable electronic module by integrating an onboard energy-harvesting facility for electrocardiogram (ECG) signal processing and personalized health monitoring. The developed electronic module provides a customizable approach to power the device using a lithium-ion battery, a series of silicon photodiode arrays, and a solar panel. The new architecture and techniques offered by the developed method include an analog front-end unit, a signal processing unit, and a battery management unit for the acquiring and processing of real-time ECG signals. The dynamic multi-level wavelet packet decomposition framework has been used and applied to an ECG signal to extract the desired features by removing overlapped and repeated samples from an ECG signal. Further, a random forest with deep decision tree (RFDDT) architecture has been designed for offline ECG signal classification, and experimental results provide the highest accuracy of 99.72%. One assesses the custom-developed sensor by comparing its data with those of conventional biosensors. The onboard energy-harvesting and battery management circuits are designed with a BQ25505 microprocessor with the support of silicon photodiodes and solar cells which detect the ambient light variations and provide a maximum of 4.2 V supply to enable the continuous operation of an entire module. The measurements conducted on each unit of the proposed method demonstrate that the proposed signal-processing method significantly reduces the overlapping samples from the raw ECG data and the timing requirement criteria for personalized and wearable health monitoring. Also, it improves temporal requirements for ECG data processing while achieving excellent classification performance at a low computing cost. Full article

This work presents the development of an amperometric biosensor for detecting aspartate aminotransferase (AST) activity in biological fluids using a platinum disk electrode as the working transducer. Optimal concentrations of substrates (aspartate, α-ketoglutarate) and the coenzyme (pyridoxal phosphate) were determined to ensure efficient biosensor operation. A semi-permeable poly-m-phenylenediamine membrane was applied to enhance selectivity against electroactive interferents. The biosensor demonstrated good stability (storage, continuous operation, and production reproducibility) and analytical performance (sensitivity 8.56 nA/min for 50 U/L AST, LOD 1 U/L, linear range 1–110 U/L). Testing with real samples showed a high correlation (R = 0.989) with spectrophotometric analysis, supporting its potential for further applications. Full article

Accurate methods for assessing food freshness through colorimetric pH response play a critical role in determining food spoilage and ensuring food quality standards. This study introduces a novel unlabeled DNA sequence, poly-dA₂₀, designed to exploit the colorimetric properties of both the single strand and the fold-back A-motif structure in conjunction with gold nanoparticles (AuNPs) under varying pH conditions. When exposed to storage temperatures of 4 °C and 25 °C, the color variations in the AuNP solution, influenced by pH level changes in mutton and sea bass samples’ different storage periods, are easily discernible to the naked eye within a minute. The ratio of UV absorption values at 527 nm and 700 nm (A₅₂₇/A₇₀₀) demonstrates a strong linear correlation with both the storage duration and pH of the food samples. Furthermore, a comprehensive analysis combining the total volatile basic nitrogen (TVB-N) value with the A₅₂₇/A₇₀₀ ratio is employed for precise assessment of food freshness. The innovative pH-responsive sensing strategy not only provides a new approach for on-site food freshness and spoilage detection systems but also serves as a valuable tool for pH-related biological detection in clinical diagnostic applications. Full article

Ovarian cancer (OC) must be detected in its early stages when the mortality rate is the lowest to provide patients with the best chance of survival. Lysophosphatidic acid (LPA) is a critical OC biomarker since its levels are elevated across all stages and increase with disease progression. This paper presents an LPA assay based on a thickness shear mode acoustic sensor with dissipation monitoring that involves a new thiol molecule 3-(2-mercaptoethanoxy)propanoic acid (HS-MEG-COOH). HS-MEG-COOH is an antifouling linker that provides (a) antifouling properties for gold substrates and (b) linking ability via its terminal carboxylic acid functional group. The antifouling ability of HS-MEG-COOH was tested in whole human serum. The new molecule was applied to the LPA assay in conjunction with a spacer molecule, 2-(2-mercaptoethoxy)ethan-1-ol (HS-MEG-OH), in a 1:1 v/v ratio. HS-MEG-COOH was covalently linked to gelsolin–actin, a protein complex probe that dissociates due to LPA-binding. LPA was detected in phosphate-buffered saline and undiluted human serum and achieved a low limit of detection (1.0 and 0.7 μM, respectively) which was below the concentration of LPA in healthy individuals. The antifouling properties of HS-MEG-COOH and the detection of LPA demonstrate the ability of the sensor to successfully identify the early-stage OC biomarker in undiluted human serum. Full article

Escherichia coli (E. coli) detection suffers from slow analysis time and high costs, along with the need for specificity. While state-of-the-art electrochemical biosensors are cost-efficient and easy to implement, their sensitivity and analysis time still require improvement. In this work, we present a paper-based electrochemical biosensor utilizing magnetic core-shell Fe₂O₃@CdSe/ZnS quantum dots (MQDs) to achieve fast detection, low cost, and high sensitivity. Using electrochemical impedance spectroscopy (EIS) as the detection technique, the biosensor achieved a limit of detection of 2.7 × 10² CFU/mL for E. coli bacteria across a concentration range of 10²–10⁸ CFU/mL, with a relative standard deviation (RSD) of 3.5781%. From an optical perspective, as E. coli concentration increased steadily from 10⁴ to 10⁷ CFU/mL, quantum dot fluorescence showed over 60% lifetime quenching. This hybrid biosensor thus provides rapid, highly sensitive E. coli detection with a fast analysis time of 30 min. This study, which combines the detection advantages of electrochemical and optical biosensor systems in a graphite-based paper sensor for the first time, has the potential to meet the needs of point-of-care applications. It is thought that future studies that will aim to examine the performance of the production-optimized, portable, graphite-based sensor system on real food samples, environmental samples, and especially medical clinical samples will be promising. Full article

Bladder cancer is one of the most common cancers worldwide. Despite its high incidence, cystoscopy remains the currently used diagnostic gold standard, although it is invasive, expensive and has low sensitivity. As a result, the cancer diagnosis is mostly late, as it occurs following the presence of hematuria in urine, and population screening is not allowed. It would therefore be desirable to be able to act promptly in the early stage of the disease with the aid of biosensing. The use of devices/tools based on genetic assessments would be of great help in this field. However, the genetic differences between populations do not allow accurate analysis in the context of population screening. Current research is directed towards the discovery of universal biomarkers present in urine with the aim of providing an approach based on a non-invasive, easy-to-perform, rapid, and accurate test that can be widely used in clinical practice for the early diagnosis and follow-up of bladder cancer. An efficient biosensing device may have a disruptive impact in terms of patient health and disease management, contributing to a decrease in mortality rate, as well as easing the social and economic burden on the national healthcare system. Considering the advantage of accessing population screening for early diagnosis of cancer, the main challenges and future perspectives are critically discussed to address the research towards the selection of suitable biomarkers for the development of a very sensitive biosensor for bladder cancer. Full article

Surface plasmon resonance (SPR) biosensors have experienced rapid development in recent years and have been widely applied in various fields. Angular-interrogation SPR biosensors play an important role in the field of biological detection due to their advantages of reliable results and high stability. However, angular-interrogation SPR biosensors also suffer from low detection sensitivity, poor real-time performance, and limited dynamic detection range, which seriously restricts their application and promotion. Therefore, we designed an angular-interrogation SPR biosensor based on black phosphorus (BP)/graphene two-dimensional (2D) van der Waals heterojunction (vdWhs). On the basis of using the angle-fixed method, this biosensor not only has good real-time performance but also detection sensitivity enhancement. The optical anisotropy characteristic of BP is used to widen the dynamic detection range of biosensors. The simulation results show that the maximum detection sensitivity of the proposed biosensor is 258.6 deg/RIU. Compared with the bare-Ag film structure biosensor, the detection sensitivity was enhanced by 209.2% by 2D vdWhs. The use of anisotropic 2D material BP can not only enhance the detection sensitivity but also widen the detection range. When the fixed incident angle is θ = 5 deg, a maximum dynamic detection range enhanced factor of 123.1% can be achieved, and a detection sensitivity of 185.2 deg/RIU in the corresponding interval can be obtained. The proposed biosensor in this study has potential broad application prospects in several fields, such as biological detection. Full article

Over the past few years, significant progress has been made in DNA origami technology due to the unrivaled self-assembly properties of DNA molecules. As a highly programmable, addressable, and biocompatible nanomaterial, DNA origami has found widespread applications in biomedicine, such as cell scaffold construction, antimicrobial drug delivery, and supramolecular enzyme assembly. To expand the scope of DNA origami application scenarios, researchers have developed DNA origami structures capable of actively identifying and quantitatively reporting targets. Optical DNA origami biosensors are promising due to their fast-to-use, sensitive, and easy implementation. However, the conversion of DNA origami to optical biosensors is still in its infancy stage, and related strategies have not been systematically summarized, increasing the difficulty of guiding subsequent researchers. Therefore, this review focuses on the universal strategies that endow DNA origami with dynamic responsiveness from both de novo design and current DNA origami modification. Various applications of DNA origami biosensors are also discussed. Additionally, we highlight the advantages of DNA origami biosensors, which offer a single-molecule resolution and high signal-to-noise ratio as an alternative to traditional analytical techniques. We believe that over the next decade, researchers will continue to transform DNA origami into optical biosensors and explore their infinite possible uses. Full article

In this study, we detected the expression levels of miR-21 in 38 clinical urine samples, obtained from 10 patients with PCa (with each sample obtained at three time points: before surgery, 1 month after surgery, and 3 months after surgery), 3 patients with benign prostatic hypertrophy (BPH), and 5 healthy subjects (as a control group). All of the samples were examined using a silver nanoparticle-based biosensor, and the sensitivity of the biosensor was simultaneously confirmed via qRT-PCR. The results were further analyzed together with clinical data such as PSA values and cancer stages. The sensitivity of the biosensor ranged up to 100 fM, and it presented a rather high selectivity rate. Our results indicated a significantly decreased expression level of miR-21 in the patient cases at 3 months post-surgery when compared with pre-surgery levels (p-value < 0.001). In addition, when distinguishing the differences in the expression level of miR-21 between healthy subjects and patients with PCa or BPH, both groups showed highly significant differences (p = 0.008 and p < 0.001, respectively). The results strongly suggest that the proposed miR-21 biosensor can be used as an auxiliary screening tool for the early detection of PCa and may effectively facilitate tracking of the progression of PCa, thus enabling more accurate healthcare decision making. Full article

In this research, a novel interdigitated gear-shaped, graphene-based electrochemical biosensor was developed for the detection of dopamine (DA). The sensor’s innovative design improves the active surface area by 94.52% and 57% compared to commercially available Metrohm DropSens 110 screen-printed sensors and printed circular sensors, respectively. The screen-printed electrode was fabricated using laser processing and modified with graphene polyaniline conductive ink (G-PANI) to enhance its electrochemical properties. Fourier Transform Infrared (FTIR) Spectroscopy and X-ray diffraction (XRD) were employed to characterize the physiochemical properties of the sensor. Dopamine, a neurotransmitter crucial for several body functions, was detected within a linear range of 0.1–100 µM, with a Limit of Detection (LOD) of 0.043 µM (coefficient of determination, R² = 0.98) in phosphate-buffer saline (PBS) with ferri/ferrocyanide as the redox probe. The performance of the sensor was evaluated using cyclic voltammetry (CV) and Chronoamperometry, demonstrating high sensitivity and selectivity. The interdigitated gear-shaped design exhibited excellent repeatability, with a relative standard deviation (RSD) of 1.2% (n = 4) and reproducibility, with an RSD of 2.3% (n = 4). In addition to detecting dopamine in human serum, the sensor effectively distinguished dopamine in a ternary mixture containing uric acid (UA) and ascorbic acid (AA). Overall, this novel sensor design offers a reliable, disposable, and cost-effective solution for dopamine detection, with potential applications in medical diagnostics and neurological research. Full article

Receptor-based biosensors often suffer from slow analyte diffusion, leading to extended assay times. Moreover, existing methods to enhance diffusion can be complex and costly. In response to this challenge, we presented a rapid and cost-effective technique for fabricating concave magnetic-responsive hydrogel discs (CMDs) by straightforward pipetting directly onto microscope glass slides. This approach enables immediate preparation and customization of hydrogel properties such as porosity, magnetic responsiveness, and embedded particles and is adaptable for use with microarray printers. The concave design increased the surface area by 43% compared to conventional hemispherical hydrogels, enhancing diffusion rates and accelerating reactions. By incorporating superparamagnetic particles, the hydrogels become magnetically responsive, allowing for stirring within reagent droplets using magnets to improve mixing. Our experimental results showed that CMDs dissolved approximately 2.5 times faster than hemispherical ones. Numerical simulations demonstrated up to a 46% improvement in diffusion speed within the hydrogel. Particles with lower diffusion coefficients, like human antibodies, benefited most from the concave design, resulting in faster biosensor responses. The increased surface area and ease of fabrication make our CMDs efficient and adaptable for various biological and biomedical applications, particularly in point-of-care diagnostics where rapid and accurate biomarker detection is critical. Full article

Single-molecule fluorescence spectroscopy offers unique capabilities for the low-concentration sensing and probing of molecular dynmics. However, employing such a methodology for versatile sensing and diagnostics under point-of-care demands device miniaturization to lab-on-a-chip size. In this study, we numerically design metalenses with high numerical aperture (NA = 1.1), which are composed of silicon nitride nanostructures deposited on a waveguide and can selectively focus guided light into an aqueous solution at two wavelengths of interest in the spectral range of 500–780 nm. Despite the severe chromatic focal shift in the lateral directions owing to the wavelength-dependent propagation constant in a waveguide, segmented on-chip metalenses provide perfectly overlapping focal volumes that meet the requirements for epi-fluorescence light collection. We demonstrate that the molecule detection efficiencies of metalenses designed for the excitation and emission wavelengths of ATTO 490LS, Alexa 555, and APC-Cy7 tandem fluorophores are sufficient to collect several thousand photons per second per molecule at modest excitation rate constants. Such sensitivity provides reliable diffusion fluorescence correlation spectroscopy analysis of single molecules on a chip to extract their concentration and diffusion properties in the nanomolar range. Achromatic on-chip metalenses open new avenues for developing ultra-compact and sensitive devices for precision medicine and environmental monitoring. Full article